Extending the Time for Thrombolysis in Emergency Neurological Deficits

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 180 participants.

Also called NCT00887328

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 180 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT00887328
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Australia, Finland, New Zealand (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT00887328. Randomized; triple masking; primary purpose treatment. Start 2010-06 (registry gives no type); primary completion 2018-08-27 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Extending the Time for Thrombolysis in Emergency Neurological Deficits
Acronym
EXTEND
Condition
Stroke
Intervention (Drug)
Tissue Plasminogen Activator (Alteplase)
Intervention (Drug)
Placebo
Lead sponsor
Neuroscience Trials Australia (class: other)
Collaborator
Commonwealth Scientific and Industrial Research Organisation, Australia (class: other government)
Collaborator
University of Melbourne (class: other)
Collaborator
Melbourne Health (class: other)
Collaborator
The Florey Institute of Neuroscience and Mental Health (class: other)

Record details

Record id
cardio:ct-nct00887328
Content hash
4d55106d40bbf8653562600f37e1b1e191e443687f98e40596f3791a150c19b0